A neurological hospital in London had a string of women with psychosis like symptoms which turned out to be caused by autoimmune encephalitis. The study reveals a larger role for autoimmune disease in mental illness. The study suggests that conditions such as schizophrenia can be treated with drugs that target the immune system, leading to a new field of study and understanding.
Fifteen years ago, a string of women at a neurological hospital in London all showed signs of the same strange illness. Some were stiff and stuporous, while others were experiencing seizures or issues with movement. But their experiences had all begun with what seemed like textbook episodes of psychosis, complete with agitation, hallucinations and delusions. In the throes of those symptoms, some had gone to emergency departments or psychiatric hospitals. Their early notes read to neuropsychiatrist Thomas Pollak as classic cases of mental ill health. But it turned out that these people actually had a condition called autoimmune encephalitis , inflammation of the brain caused by an assault from the immune system. The fact that an autoimmune condition could produce psychosis shattered the usual divide between psychiatric and neurological illnesses and “kind of blew my mind”, says Pollak.
In the years since, Pollak, now at King’s College London, has helped define an emerging field of study, one beginning to show that autoimmune disease plays a larger role in mental illness than conventional wisdom suggests. This link isn’t completely new. Studies have long shown that people with schizophrenia are. But the work of Pollak and others has dramatically expanded the scope of potential overlap, suggesting that the autoimmune system may play a role in many conditions, from All this suggests an exciting possibility: that some cases of apparent mental health conditions could be treated with drugs that target the immune system, a solution that few doctors routinely consider. “The immune system is playing a role in behaviour much more than we appreciate,” says psychiatrist
The human immune system is a double-edged sword. The same thing that neutralises foreign pathogens like bacteria and viruses can misfire, turning the weapons in its arsenal, such as antibodies, cytokines and T-cells, against the body’s own tissues. Broadly, this phenomenon is called autoimmunity. “We know that every single organ system is affected by autoimmunity,” says
The relationship between the immune system and mental health is most clear when it comes to psychotic conditions, such as schizophrenia. About 20 years ago, scientists, where a specific type of antibody binds to receptors in the brain, causing neuropsychiatric symptoms including delusions, hallucinations, memory loss, bizarre behaviour and more.
A man who lost decades of memories to autoimmune encephalitis holds up a slide film of himself as a college student
Autoimmune encephalitis is “just a wonderful diagnosis to be able to make, because you can literally get people better and transform their lives with relatively simple treatments”, says, a psychiatrist at the University of Oxford who studies psychotic illness. But it is a diagnosis that can be missed if people who seem to have mental health conditions aren’t screened for autoantibodies – malfunctioning immune cells that attack the body – or other signs of autoimmune dysfunction. The women Pollak saw were referred to the hospital once they started to show neurological symptoms, such as seizures and catatonia, butdied by suicide after doctors failed to carry out a lumbar puncture to test for the illness, which an inquest jury found “possibly contributed” to her death.
hypothesised that autoimmunity might play a role in schizophrenia. Since the discovery of anti-NMDAR encephalitis, interest in the overlap between immunology and psychology has intensified. Occasionally, scientists can pinpoint exactly how autoimmune reactions lead to mental ill health. In anti-NMDAR encephalitis, for example, antibodies clearly attack the brain. For other people, autoimmune reactions seem to be relevant, but scientists don’t yet know precisely how.
Lennox’s research suggests around 5 per cent of those diagnosed with schizophrenia have antibodies in their blood, even if they don’t meet the high bar of an autoimmune encephalitis diagnosis. She is currently runningto see how many people with acute psychosis benefit from immunomodulating treatments, specifically intravenous immunoglobulin and the monoclonal antibody rituximab. Pollak thinks that no more than 1 per cent of people with acute psychosis have symptoms directly and concretely caused by antibodies that lead to autoimmune encephalitis. “But if you ask what I consider to be the more curious and interesting and less-blinkered question” – how many are experiencing some kind of brain-related autoimmunity or inflammation – then “the numbers start to get a little bit bigger”, he says.
Bartley is looking at the problem from a wider angle, too. In his view, focusing on the autoantibodies known to cause conditions like encephalitis isn’t thinking big enough. He thinks there could be other, currently unknown autoantibodies contributing to psychosis and other forms of psychiatric illness. “Rather than testing for a dozen autoantibodies in schizophrenia that people have tested for 200 times,” he says, “why don’t we widen the aperture and try to test for as many possible autoantibodies as we can?”
of creating a quintillion types of antibodies. Many aren’t harmful. But Bartley’s hypothesis is that, within the massive pool of possibilities, an untold number of autoantibodies may contribute to symptoms of mental illness. His lab recently identified three novel autoantibodies that may do so, and is in the process of publishing a paper on that finding, he says.
to prove the connection. If animals develop symptoms when they are introduced to cloned versions of the autoantibodies, that would be an important signal, he says. If removing the autoantibodies causes symptoms to disappear, that is an even stronger sign that hints at potential treatments for humans.
at the Baylor College of Medicine in Texas. In 2018, he was part of a research team involved in an extraordinary case. At its centre waswho had been institutionalised in a psychiatric hospital in New York state for about two decades with what was thought to be schizophrenia. Her symptoms were so severe and resistant to treatment that Zogbhi’s team eventually referred her to Columbia University in New York City for a full medical workup. Eventually, a team of specialists found that she had biomarkers suggestive of the autoimmune disease lupus, though she didn’t have the condition’s hallmark symptoms. Even though the researchers didn’t know exactly what condition the woman had, they treated her with drugs that dampen the immune system, and it worked. After years spent in a near-catatonic state, she began to recover within months of starting the immune therapies. The case shook Zoghbi to the core. The treatment was experimental, breaking with the medical system’s preference for testing drugs at scale and working to understand the mechanisms behind medicine. But it also did for this patient what no psychiatric treatment had achieved in 20 years.
Experiences like this one hint that known forms of autoimmune-related mental health conditions may be only the tip of the iceberg. “You can only diagnose what you have diagnostic tests for,” says Zoghbi. It could be that many different autoimmune processes are causing or contributing to symptoms of mental illness – not only in the relatively well-researched realm of psychosis, but alsoranging from obsessive-compulsive disorder to depression. In a small 2025 study, for example, researchers found autoantibodies in the blood serum of eight out of 20 veterans with both post-traumatic stress disorder and a history of a traumatic brain injury.
Experts aren’t arguing that all or even most people who have been diagnosed with mental health conditions actually have an autoimmune disease. Pollak, for one, finds himself walking a tightrope as research accumulates. As
There is a real danger, says Pollak, in blaming everything on the immune system and throwing treatments – many with high price tags and long lists of side effects – at people without careful analysis. “I have had patients sell assets to try to get treatment in another country I have been absolutely convinced from the start that that treatment would not work,” he says. Probably only a small fraction of people with symptoms of mental illness fall into this camp. “But the stakes are so high for that very small fraction that we have to get to the answer,” says Zoghbi.
Trying to find effective treatments for mental health conditions can feel frustrating. “What we have in psychiatry is basically chemotherapy for the brain,” says Miller. Blunt instruments work fairly well across the board, but don’t achieve precise results – and can come with brutal side effects.
work; doctors know only that they do. To that end, much of Pollak’s current research focuses on better understanding what antipsychotic drugs do to the body, and specificallyto find out. Schmack and her team trigger the immune system of mice to attack their brains, in an approximation of what they think happens in some people with psychosis. Working with these models allows the researchers to analyse how antipsychotic drugs affect the mice’s immune system and behaviour. If their research suggests that antipsychotics work by altering the immune system, that would further support a link between the immune system and mental illness – and the idea of treating more people with drugs that directly target the immune system. “The good thing about immune drugs is we already have a whole array of drugs available,” says Schmack. For example, the immunosuppressant methotrexate, which is already used to treat autoimmune conditions including rheumatoid arthritis and psoriasis, isinclude plasmapheresis – a procedure through which plasma containing harmful antibodies is filtered from the rest of the blood, discarded and replaced with new fluid – and drugs such as corticosteroids, IVIG and rituximab.
Vo Trung Dung/Look at Sciences/Science Photo Library Other countries may soon join Germany in expanding screening. In the US, researchers at Columbia University have embarked on an ambitious effort to screen every person institutionalised in New York state’s psychiatric hospitals – a system that houses around 3000 people – for biomarkers of 12 autoimmune, metabolic or genetic underpinnings of mental health conditions. If initial blood tests are positive, people will be recommended for follow-up testing, such as a lumbar puncture. They could then receive “treatments that are fundamentally different than the standard treatments that are given for people with severe mental illness”, says psychiatrist
It is too soon to say what proportion of people will test positive for any of those conditions, he says. But “to me, it doesn’t matter how small that percentage is”, he says. “If is non-zero, this is worthwhile to do.” A non-zero percentage would also suggest that similar screening processes would be worth duplicating in other health systems, says Kushner. If even a few cases were caught and treated quickly, those people might “avoid many years currently lost to mental health disability”, he says. “To identify the treatable entities as early as possible in their trajectory is a major responsibility for the field.”
The solution isn’t to replace mental healthcare with immune treatments, says Pollak, but to find an approach that blends the two. Identifying and properly treating people with an autoimmune condition could revolutionise their care and lead to a sea change in our conception of what mental illness is and can be – benefits that shouldn’t be understated. But many will still benefit from psychotherapy and other cornerstones of traditional psychiatric medicine, says Pollak. There is no reason to cast those aside.
more than we ever realised, and if people who appear to be experiencing the latter can also access neurological screenings, that will inevitably transform treatments – to the extent that some will be cured of seemingly intractable illnesses. Although that won’t apply to the majority, the effects are too profound to be ignored. “A smart future medicine,” says Pollak, “is going to combine all of these different aspects at the same time.”
Autoimmune Encephalitis Mental Illness Immune System Psychosis Neurological Illness
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
StarkWare cuts jobs in reorganization as Starknet revenue plunges 99% from peakDays after unveiling a quantum-safe bitcoin method, a StarkWare researcher was tapped to lead a new applications unit as Layer-2 revenue dries up.
Read more »
Foundry unveils Zcash block explorer as mining pool reaches 30% of hashrateThe mining pool comes alongside the unveiling of Zcashinfo.com, a block explorer with real-time network and mining data.
Read more »
One woman, three autoimmune diseases: CAR-T therapy vanquishes ultra-rare disease trioFourteen months after treatment with engineered immune cells, the recipient has no symptoms and doesn’t need to take medication. Fourteen months after treatment with engineered immune cells, the recipient has no symptoms and doesn’t need to take medication.
Read more »
The Invisible Neutrino: Unveiling the Secrets of Mass and MysteryThis article explores the perplexing nature of neutrinos, focusing on their mass and the challenges they pose to our understanding of particle physics. It delves into the concept of right-handed neutrinos, the seesaw mechanism, and the differences between electrons and neutrinos. The article poses fundamental questions about the nature of neutrinos and their relationship with mass, potentially leading to a deeper understanding of the universe.
Read more »
Sister's kidney donation saves little sister battling autoimmune diseaseSAN ANTONIO - April is National Donate Life Month and sadly there is always an urgent need for organ donors.According to Donate Life Texas, organ donation can save up to eight lives.Madison Rodgers saw her little sister
Read more »
Apple TV's New Movie Based On Popular 76-Year-Old Comics Strip Gets First ImagesA long-running and beloved animated franchise, which got its start as a comic strip in the 1950s, is unveiling its next film with a first-look image.
Read more »